Back to Lung Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT02020252

NCT02020252
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You are an adult (18 or older)
  • You speak English
  • You are a woman or a man
  • You have recently been diagnosed with lung, gastric (stomach), or pancreatic cancer
  • You are attending your first oncology (cancer care) appointment at the University of Chicago outpatient oncology clinics

Who may not be able to join:

  • There are no listed exclusion criteria for this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
University of Chicago
Registry
clinicaltrials_gov
Start date
26 November 2013
Est. completion
1 December 2018

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Clinical Trials Attitudes, Knowledge, and Interest

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov